Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
---|
01/23/2014 | WO2014014698A2 Bitopic muscarinic agonists and antagonists and methods of synthesis and use thereof |
01/23/2014 | WO2014013465A2 Salts and hydrates of antipsychotics |
01/23/2014 | WO2014013181A1 Thiophene derivatives used in the treatment of diabetes |
01/23/2014 | WO2014012858A1 Pyridinone derivatives as tissue transglutaminase inhibitors |
01/23/2014 | WO2013082345A8 Aryl dihydropyridinones and piperidinones as mgat2 inhibitors |
01/23/2014 | WO2013014665A8 Intermediate compounds and process for the preparation of lurasidone and salts thereof |
01/23/2014 | US20140024687 Combinations of Vascular Disrupting Agents with Inhibitor of Apoptosis Proteins Antagonists |
01/23/2014 | US20140024671 Compositions and methods for inhibiting cytochrome p450 |
01/23/2014 | US20140024657 Small molecule inhibitors of necroptosis |
01/23/2014 | US20140024656 [1,3,4] oxadiazole derivative and application thereof |
01/23/2014 | US20140024647 Aromatic heterocyclic derivative having trpv4-inhibiting activity |
01/23/2014 | US20140024636 Sulfamide derivative having an adamantyl group and its pharmaceutically acceptable salt |
01/23/2014 | US20140024618 Indole compounds as an inhibitor of cellular necrosis |
01/23/2014 | US20140024583 Organic compounds |
01/23/2014 | US20140023642 1-(Arylmethyl)quinazoline-2,4(1H,3H)-diones as PARP Inhibitors and the Use Thereof |
01/23/2014 | US20140023611 Compounds and methods for inhibiting phosphate transport |
01/22/2014 | EP2687526A1 Crystalline forms of a 2-thiazolyl- 4-quinolinyl-oxy derivative, a potent HCV inhibitor |
01/22/2014 | EP2687524A1 Azole derivative |
01/22/2014 | EP2687511A1 Pyridinone derivatives as tissue transglutaminase inhibitors |
01/22/2014 | EP2686317A2 Raf kinase inhibitors |
01/22/2014 | EP2686316A1 N-(1,2,5-oxadiazol-3-yl)pyridinecarboxamides and use thereof as herbicides |
01/22/2014 | EP2686315A1 N-(1,2,5-oxadiazol-3-yl)-, n-(tetrazol-5-yl)- and n-(triazol-5-yl)bicycloarylcarboxamides and their use as herbicides |
01/22/2014 | EP2686314A1 6,5-heterocyclic propargylic alcohol compounds and uses therefor |
01/22/2014 | EP2686313A1 Benz imidazole derivatives as inhibitors of glutaminyl cyclase |
01/22/2014 | EP2686312A1 N- cyclopropyl - n- piperidinylbenzamides as gpr119 modulators |
01/22/2014 | EP2686311A1 Fungicide hydroximoyl-tetrazole derivatives |
01/22/2014 | EP2686309A1 Herbicide safener compositions |
01/22/2014 | EP2686302A1 Sulfonamide compounds having trpm8 antagonistic activity |
01/22/2014 | EP2685828A1 Substituted 3-azabicyclo[3.1.0]hexane derivatives useful as ccr2 antagonists |
01/22/2014 | CN103524442A Pyrimidine compound, triazine compound and application thereof as medicine |
01/22/2014 | CN103524432A Method for preparing 2,3-dihydroquinazoline-4(3H)-ketone derivatives |
01/22/2014 | CN103524420A Keratin dyeing compounds, keratin dyeing compositions containing said compounds, and use thereof |
01/22/2014 | CN103524419A Group of 3-trifluoromethyl pyrazole compounds |
01/22/2014 | CN103524418A 3-methyl pyrazol compounds |
01/22/2014 | CN103524417A 3-methyl-4-formyl pyrazol compounds |
01/22/2014 | CN103524407A 2-fluorine-3-pyridine formyl compounds |
01/22/2014 | CN103524392A Azetidines as mek inhibitors for the treatment of proliferative diseases |
01/22/2014 | CN103518745A Dialdehyde-built nitrogen-containing or oxygen-containing heterocyclic compound with insecticidal activity and preparation method thereof |
01/22/2014 | CN102250085B Bifendate derivative and use thereof in preparation of drugs for treating autoimmune diseases |
01/21/2014 | US8633236 Compounds, compositions and methods |
01/21/2014 | US8633210 Triazole compounds useful as protein kinase inhibitors |
01/21/2014 | US8633208 6-1H-imidazo-quinazoline and quinolines derivatives, new MAO inhibitors and imidazoline receptor ligands |
01/21/2014 | CA2691442C Antiviral compounds |
01/21/2014 | CA2657096C Human protein tyrosine phosphatase inhibitors and methods of use |
01/21/2014 | CA2609288C Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide - derivatives as factor xa inhibitors |
01/21/2014 | CA2605050C Histone deacetylase inhibitors |
01/16/2014 | WO2014011513A1 Sulfonyl containing benzothiazole inhibitors of endothelial lipase |
01/16/2014 | WO2014011461A1 Amide or urea substituted benzothiazole derivatives as inhibitors of endothelial lipase |
01/16/2014 | WO2014010325A1 Polymerizable compound, polymerizable composition, polymer, optically anisotropic body, and method for producing polymerizable compound |
01/16/2014 | WO2014009495A1 Antiproliferative benzo [b] azepin- 2 - ones |
01/16/2014 | WO2014009447A1 ARYL SULTAM DERIVATIVES AS RORc MODULATORS |
01/16/2014 | WO2014008992A1 Pyrimidine pyrazolyl derivatives |
01/16/2014 | US20140018401 Cytochrome p450 inhibitors and uses thereof |
01/16/2014 | US20140018399 Mitotic kinesin inhibtors and methods of use thereof |
01/16/2014 | US20140018389 Hepatitis C Virus Inhibitors |
01/16/2014 | US20140018377 Aminopropenoates as Fungicides |
01/16/2014 | US20140018366 Bitopic muscarinic agonists and antagonists and methods of synthesis and use thereof |
01/16/2014 | US20140018365 Pharmaceutically active compounds as axl inhibitors |
01/16/2014 | US20140018335 Indole derivative, and pharmacologically acceptable salt thereof |
01/16/2014 | US20140018326 Sulfonamides as hib protease inhibitors |
01/16/2014 | US20140017199 Modulators of pharmacokinetic properties of therapeutics |
01/16/2014 | US20140017195 Hepatitis C Virus Inhibitors |
01/16/2014 | CA2877187A1 Antiproliferative benzo [b]azepin-2-ones |
01/16/2014 | CA2876449A1 Aryl sultam derivatives as rorc modulators |
01/15/2014 | EP2684874A1 Fused bicyclic derivatives of 2,4-diaminopyrimidine as alk and C-met inhibitors |
01/15/2014 | EP2684871A1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives |
01/15/2014 | EP2683713A1 Isoxazole derivatives |
01/15/2014 | EP2683710A1 Soluble guanylate cyclase activators |
01/15/2014 | EP2683694A1 Androgen receptor antagonists and uses thereof |
01/15/2014 | EP2683690A1 Quinolinone derivatives |
01/15/2014 | EP2683689A1 Fluoro-pyridinone derivatives useful as antibacterial agents |
01/15/2014 | EP2683378A2 Amorphous form of lopinavir and ritonavir mixture |
01/15/2014 | CN103517901A 1,4-oxazepines as bace1 and/or bace2 inhibitors |
01/15/2014 | CN103517900A Fungicide hydroximoyl-tetrazole derivatives |
01/15/2014 | CN103517898A Novel 3-hydroxyisothiazole 1-oxide derivative |
01/15/2014 | CN103517896A Quinolinone derivatives |
01/15/2014 | CN103509010A Organic light-emitting compound and organic light-emitting device including the same |
01/15/2014 | CN103509009A 2-substituted-5-phenyl furan compound, and preparation method, pharmaceutical composition and application thereof |
01/15/2014 | CN103508980A Benzothiazine-4-one derivative, and preparation method and applications thereof |
01/15/2014 | CN102617562B Thiazole derivant and preparation method and use thereof |
01/15/2014 | CN102558535B Amphiphilic block copolymer connected through molecular glue and synthesis method and application of copolymer |
01/15/2014 | CN102203067B Hedgehog pathway modulators |
01/14/2014 | US8629285 Imidazole compounds that modulate HSP90 activity |
01/14/2014 | US8629157 Pyrrolidine compounds which modulate the CB2 receptor |
01/14/2014 | CA2630714C S1p receptor modulating compounds and use thereof |
01/14/2014 | CA2628074C Aminodihydrothiazine derivative |
01/09/2014 | WO2014007395A1 Pyrazole or thiazole derivative, salt thereof, and pest control agent |
01/09/2014 | WO2014007228A1 Compound having agonistic activity on somatostatin receptor, and use thereof for medical purposes |
01/09/2014 | WO2014006402A1 Orexin receptor antagonists |
01/09/2014 | WO2012162254A8 Inhibitors of lrrk2 kinase activity |
01/09/2014 | US20140011996 N-piperidinyl acetamide derivatives as calcium channel blockers |
01/09/2014 | US20140011961 Precursor compound connected to solid support for manufacturing 18f radiopharmaceutical, method for manufacturing same, and application thereof |
01/09/2014 | US20140011808 1,2-disubstituted heterocyclic compounds |
01/09/2014 | US20140011801 Heteroaryl quinazoline derivatives |
01/09/2014 | US20140011799 Sulfonyl containing benzothiazole inhibitors of endothelial lipase |
01/09/2014 | US20140011796 Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer |
01/08/2014 | EP2682393A1 Inhibitors of HCV NS5A comprising a bicyclic core. |
01/08/2014 | EP2682390A1 2-aminothiazole derivative, preparation method, and use |
01/08/2014 | EP2681210A1 1,4 thiazepines/sulfones as bace1 and/or bace2 inhibitors |
01/08/2014 | EP2681206A1 Mst1 kinase inhibitors and methods of their use |